{"id":670,"name":"Versant Ventures","slug":"versant-ventures","website":"https://www.versantventures.com","hqGeo":"San Francisco, CA","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare","Other"],"excludedSectors":[],"checkSizeMin":1000000,"checkSizeMax":10000000,"thesisSummary":"Versant focuses exclusively on creating and financing innovative biotechnology companies pushing the frontier of cell and gene therapy.","thesisNarrative":null,"logoUrl":null,"aumUsd":5500000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Jasper Therapeutics","companyUrl":null,"stage":null,"sector":"Cell Therapy","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Revolutio","companyUrl":null,"stage":null,"sector":"Immuno-Oncology","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versant Venture Capital VIII, L.P.  (CIK 0001832242)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Versant Ventures","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versant Venture Capital IX, L.P.  (CIK 0001947469)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Versant Ventures","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versant Venture Capital SPV I (SAB), L.P.  (CIK 0002020185)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Versant Ventures","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versant Vantage II, L.P.  (CIK 0001832235)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Versant Ventures","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versant Voyageurs II, L.P.  (CIK 0001832243)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Versant Ventures","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versant Voyageurs III, L.P.  (CIK 0001947466)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Versant Ventures","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Versant Vantage III, L.P.  (CIK 0001947467)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning Versant Ventures","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":11,"partners":[{"id":10057,"name":"Kevin Grove","title":"Venture Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/kevin-grove-8836b62a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10058,"name":"Max Eisenberg","title":"Chief Operating Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/max-eisenberg-98338b5","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10059,"name":"Carlo Rizzuto","title":"Managing Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/carlorizzuto","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10060,"name":"Alexander Mayweg","title":"Managing Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/mayweg","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10061,"name":"Brian Atwood","title":"Managing Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/brian-atwood-04014424","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10062,"name":"Nigel Sheail","title":"Venture Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/nigel-sheail-a2437144","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10063,"name":"Robin Praeger","title":"Managing Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/robin-praeger-65ba2912","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10064,"name":"Zachary Sweeney","title":"Venture Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/zachary-sweeney-5b7ab61a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10065,"name":"Jerel Davis","title":"Managing Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/jereldavis","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":10056,"name":"Don Milder","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/don-milder-b40857225","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":1145,"name":"Bijan Salehizadeh","title":"Managing Partner","seniority":null,"focusTags":["Biotech","Oncology","Cell Therapy"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":6492,"name":"Breed Reply","slug":"breed-reply","logoUrl":null,"website":"https://www.reply.com/","stageFocus":[],"sectorTags":["Healthcare","Security"],"hqGeo":null},{"id":6827,"name":"Force Over Mass","slug":"force-over-mass","logoUrl":null,"website":"https://www.fomcap.com/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Other","Fintech","SaaS","Healthcare","EdTech"],"hqGeo":null},{"id":1548,"name":"Health Innovation Capital","slug":"health-innovation-capital","logoUrl":null,"website":"https://www.healthinnovation.vc/","stageFocus":["Seed","Pre-Seed"],"sectorTags":["Healthcare"],"hqGeo":"Boston, MA"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Other","Healthcare"],"hqGeo":"Austin, TX"},{"id":1369,"name":"Sonder Health Ventures","slug":"sonder-health-ventures","logoUrl":null,"website":"https://sondercapital.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","Other"],"hqGeo":"Austin, TX, USA"},{"id":11533,"name":"Nova Health Fund","slug":"nova-health-fund","logoUrl":null,"website":"https://www.independenthealth.com/","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare","Other"],"hqGeo":"Minneapolis, MN"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-07-18T06:51:24.542Z"}